Similar Papers

Paper Title
Journal
Date
Author
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
...
The Lancet Respiratory Medicine | VOL. 9
, et. al. ...
01 Jan 2020
Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial
Masataka Kuwana ... Arata Azuma
Modern Rheumatology | VOL. 31
Masataka Kuwana, et. al.Masataka Kuwana ... Arata Azuma
23 Apr 2020
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
Bruno Crestani ... Michael Kreuter
The Lancet Respiratory Medicine | VOL. 7
Bruno Crestani, et. al.Bruno Crestani ... Michael Kreuter
14 Sep 2018
Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data.
Joseph A Lasky ... Shaun Bender
Advances in Therapy | VOL. 37
Joseph A Lasky, et. al.Joseph A Lasky ... Shaun Bender
07 Aug 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor – 2025
Josef Smolen
Annals of the Rheumatic Diseases | VOL. -
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis
Francis Berenbaum ... Marc Buyse
Annals of the Rheumatic Diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.